Valuation McKesson Corporation

Stocks

Market Closed - NYSE 21:00:02 30/09/2026 BST			5-day change	1st Jan Change
853.81 ^USD	-1.27%		-4.20%	+4.09%

09-14	McKesson Continues to Face Medium-Term Headwinds From Declining Employer Coverage of GLP-1, RBC Says	MT
09-14	McKesson Corporation Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-14-2026 07:45 AM

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	45,858	48,757	70,547	84,343	105,996	100,830	-	-
Change	-	6.32%	44.69%	19.56%	25.67%	-4.87%	-	-
Enterprise Value (EV) ¹	48,205	49,673	71,593	84,306	108,547	104,899	104,017	102,734
Change	-	3.05%	44.13%	17.76%	28.75%	-3.36%	-0.84%	-1.23%
P/E	42.3x	14.2x	24x	26.2x	22.5x	22.2x	17.6x	15.4x
PBR	-19.5x	-27.3x	-36.5x	-41.3x	-47.8x	-42.1x	-51.6x	-110x
PEG	-	0x	-2.3x	1.8x	0.5x	13.42x	0.7x	1.1x
Capitalization / Revenue	0.17x	0.18x	0.23x	0.23x	0.26x	0.23x	0.22x	0.2x
EV / Revenue	0.18x	0.18x	0.23x	0.23x	0.27x	0.24x	0.23x	0.21x
EV / EBITDA	9.14x	9.27x	13.5x	14x	15.7x	14x	12.8x	11.6x
EV / EBIT	9.94x	9.96x	14.6x	15x	16.8x	14.9x	13.6x	12.4x
EV / FCF	12.4x	10.8x	19.7x	16.1x	20.1x	22.2x	17.2x	15.4x
FCF Yield	8.09%	9.26%	5.07%	6.2%	4.98%	4.51%	5.8%	6.49%
Dividend per Share ²	1.83	2.09	2.4	2.75	3.17	3.641	3.684	4.446
Rate of return	0.6%	0.59%	0.45%	0.41%	0.37%	0.42%	0.43%	0.51%
EPS ²	7.23	25.03	22.39	25.72	38.38	39.02	49.06	56.15
Distribution rate	25.3%	8.35%	10.7%	10.7%	8.26%	9.33%	7.51%	7.92%
Net sales ¹	263,966	276,711	308,951	359,051	403,430	431,842	462,177	496,452
EBITDA ¹	5,276	5,357	5,287	6,028	6,918	7,506	8,157	8,842
EBIT ¹	4,849	4,985	4,901	5,618	6,465	7,019	7,666	8,314
Net income ¹	1,114	3,560	3,002	3,295	4,762	4,690	5,620	6,118
Net Debt ¹	2,347	916	1,046	-37	2,551	4,070	3,188	1,904
Reference price ²	306.13	356.05	536.85	672.99	865.36	864.82	864.82	864.82
Nbr of stocks (in thousands)	149,798	136,939	131,408	125,326	122,487	116,590	-	-
Announcement Date	05/05/22	08/05/23	07/05/24	08/05/25	07/05/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MCKESSON CORPORATION	22.17x	0.24x	13.97x	0.42%	101B
ELI LILLY AND COMPANY	33.68x	12.2x	24.79x	0.59%	1,056B
JOHNSON & JOHNSON	29.76x	6.61x	18.5x	2%	645B
ABBVIE INC.	33.32x	7.79x	16.11x	2.63%	465B
MERCK & CO., INC.	108.6x	6.05x	25.67x	2.29%	368B
ROCHE HOLDING AG	19.01x	4.64x	11.49x	2.87%	335B
NOVARTIS AG	20.51x	5.32x	13.17x	3.01%	275B
ASTRAZENECA PLC	20.92x	4.34x	12.36x	2.04%	255B
AMGEN INC.	26.76x	6.95x	12.37x	2.38%	229B
GILEAD SCIENCES, INC.	-45.76x	6.66x	26x	2.18%	188B
Average	26.90x	6.08x	17.44x	2.04%	391.66B
Weighted average by Cap.	32.52x	7.66x	19.10x	1.86%